Webinar: In Vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based Therapies

Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T TherapiesПодробнее

Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T Therapies

Webinar: Engineering strategies for improving adoptive T cell therapy against cancerПодробнее

Webinar: Engineering strategies for improving adoptive T cell therapy against cancer

JAX Tech Talk 53: Let's Talk Fighting Cancer with CAR-based Therapies (5Apr2022)Подробнее

JAX Tech Talk 53: Let's Talk Fighting Cancer with CAR-based Therapies (5Apr2022)

The Challenges and Strategies of NK Cell Related IO Therapy in Preclinical Drug EvaluationПодробнее

The Challenges and Strategies of NK Cell Related IO Therapy in Preclinical Drug Evaluation

CAR T Cell Webinar 28 November 2017Подробнее

CAR T Cell Webinar 28 November 2017

Improved T Cell Function and In Vivo Engraftment Of CAR-T CellsПодробнее

Improved T Cell Function and In Vivo Engraftment Of CAR-T Cells

Webinar: Human Immune System Engrafted Platforms for More Translatable Preclinical ResearchПодробнее

Webinar: Human Immune System Engrafted Platforms for More Translatable Preclinical Research

Safety and efficacy of allogeneic CAR-T cell treatmentПодробнее

Safety and efficacy of allogeneic CAR-T cell treatment

Webinar: In Vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based TherapiesПодробнее

Webinar: In Vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based Therapies

Allogeneic CAR-NK cell therapy in R/R AML/MDSПодробнее

Allogeneic CAR-NK cell therapy in R/R AML/MDS

Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)Подробнее

Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)

Addressing the major challenges to CAR-T therapy in AMLПодробнее

Addressing the major challenges to CAR-T therapy in AML

Strategies to improve CAR T-cell manufacturingПодробнее

Strategies to improve CAR T-cell manufacturing

Optimizing CAR-T therapy: regulating CAR T-cells in vivoПодробнее

Optimizing CAR-T therapy: regulating CAR T-cells in vivo

WEBINAR: CAR T Cell TherapyПодробнее

WEBINAR: CAR T Cell Therapy

CAR T-cell therapy treating myelomaПодробнее

CAR T-cell therapy treating myeloma

A novel subcutaneous CAR-T therapy for the treatment of hematological malignanciesПодробнее

A novel subcutaneous CAR-T therapy for the treatment of hematological malignancies

Webinar: Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft PlatformsПодробнее

Webinar: Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft Platforms

In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew ScharenbergПодробнее

In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg